Grace Therapeutics, Inc. - Common Stock (NQ:GRCE)

2.260 -0.020 (-0.88%)

Streaming Delayed Price Updated: 3:53 PM EDT, Apr 1, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	6,655
Open	2.400
Bid (Size)	2.270 (4)
Ask (Size)	2.290 (8)
Prev. Close	2.280
Today's Range	2.260 - 2.400
52wk Range	2.070 - 4.965
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

March 11, 2025

From Matinas BioPharma Holdings, Inc.

Via GlobeNewswire

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study

February 10, 2025

Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.

Via Benzinga

Performance

YTD	-43.5%	-43.5%
1 Month	-14.7%	-14.7%
3 Month	-41.3%	-41.3%
6 Month	-29.6%	-29.6%
1 Year	-29.6%	-29.6%

Frequently Asked Questions

Is Grace Therapeutics, Inc. - Common Stock publicly traded?

Yes, Grace Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Grace Therapeutics, Inc. - Common Stock trade on?

Grace Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Grace Therapeutics, Inc. - Common Stock?

The ticker symbol for Grace Therapeutics, Inc. - Common Stock is GRCE on the Nasdaq Stock Market

What is the current price of Grace Therapeutics, Inc. - Common Stock?

The current price of Grace Therapeutics, Inc. - Common Stock is 2.260

When was Grace Therapeutics, Inc. - Common Stock last traded?

The last trade of Grace Therapeutics, Inc. - Common Stock was at 04/01/25 03:53 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.